RxDoctor Payments Data

Edward Hosbach, DO

Family Medicine · Ft Recovery, OHNPI 1740280619

Payments from drug & device makers

$666in general payments, 2019–2025

Across 35 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$130
  • AstraZeneca$97
  • GSK$73
  • Johnson & Johnson$68
  • Pfizer$51
  • Boehringer Ingelheim$50
  • plus $199 from 9 others

What the payments were for

  • Food & beverage$63495%
  • Education$325%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$666 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$43,211
Medicare patients
229
Services billed
780

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ArexvyRsvpref3 Antigen/As01e/Pf80$24,365
ShingrixVaricella-Zoster Ge/As01b/Pf103$21,732
JardianceEmpagliflozin19$15,718
TrulicityDulaglutide13$12,397
AbrysvoRsv Vacc, Pref A And Pref B/Pf34$10,486
XareltoRivaroxaban15$7,930
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,070
Boostrix TdapDiphth,pertuss(Acell),tet Vac24$1,565
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$969
Atorvastatin Calcium139$871
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$767
Tamsulosin Hcl58$732
Memantine Hcl24$646
Levothyroxine Sodium112$570
SynthroidLevothyroxine Sodium11$483

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKArexvy, Shingrix, Anoro Ellipta$73$52,168196 claims
Boehringer IngelheimJardiance$50$15,71819 claims
PfizerAbrysvo$51$10,48634 claims
Johnson & JohnsonXarelto$68$7,93015 claims
AbbVieSynthroid$24$48311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Ft Recovery

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →